Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies Meeting Abstract


Authors: Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; Stein, E. M.; Berman, E.; Klimek, V. M.; Tallman, M. S.
Abstract Title: Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419403177
PROVIDER: wos
Notes: Meeting Abstract: 1353 -- Source: Wos
MSK Authors
  1. Meier Hsu
    102 Hsu
  2. Virginia Klimek
    105 Klimek
  3. Eytan Moshe Stein
    108 Stein
  4. Martin Stuart Tallman
    396 Tallman
  5. Bernadette M Cuello
    5 Cuello
  6. Ellin Berman
    88 Berman
  7. Sean McCarthy Devlin
    277 Devlin
  8. Michael John Mauro
    114 Mauro
  9. Jacob Lowell Glass
    13 Glass
  10. Troy Zachery Horvat
    12 Horvat
  11. Larry Wayne Buie
    11 Buie
  12. Ryan Joseph Daley
    9 Daley
  13. Amber Courtney King
    6 King